0,912  0,005  Antidiabetic
0,912  0,005  Cyclophilin D inhibitor
0,891  0,001  Alpha-N-acetylglucosaminidase inhibitor
0,889  0,005  Antiinflammatory
0,882  0,002  Angiogenesis stimulant
0,876  0,004  Caspase 9 stimulant
0,870  0,003  Antihypoxic
0,848  0,002  Aldose reductase substrate
0,838  0,004  Cardioprotectant
0,826  0,001  Alpha-mannosidase inhibitor
0,814  0,001  Mannosidase inhibitor
0,808  0,004  Cholesterol antagonist
0,806  0,004  Vasodilator, coronary
0,801  0,002  Amylase inhibitor
0,799  0,004  Antioxidant
0,798  0,004  Hypoglycemic
0,784  0,006  Respiratory analeptic
0,775  0,004  5 Hydroxytryptamine release stimulant
0,775  0,004  NOS3 expression inhibitor
0,771  0,004  Antimutagenic
0,775  0,020  Apoptosis agonist
0,750  0,005  Immunomodulator
0,747  0,008  Radioprotector
0,744  0,005  Nitric oxide antagonist
0,745  0,007  Chemoprotective
0,738  0,006  Cytostatic
0,741  0,013  Teratogen
0,749  0,026  Alpha-glucosidase inhibitor
0,731  0,009  Antihypercholesterolemic
0,716  0,002  Carcinogenic, group 2A
0,717  0,007  Antithrombotic
0,722  0,013  Embryotoxic
0,713  0,004  Apoptosis antagonist
0,717  0,009  Chemopreventive
0,709  0,005  Hepatic disorders treatment
0,707  0,008  Analeptic
0,702  0,005  Free radical scavenger
0,698  0,001  NADH dehydrogenase inhibitor
0,704  0,009  Mutagenic
0,698  0,004  Hepatoprotectant
0,691  0,005  Tumour necrosis factor alpha release inhibitor
0,689  0,005  UDP-glucuronosyltransferase substrate
0,685  0,002  Antineoplastic, alkylator
0,683  0,004  Interleukin agonist
0,685  0,007  Vasodilator, peripheral
0,679  0,008  UGT1A9 substrate
0,676  0,007  NOS2 expression inhibitor
0,674  0,005  DNA synthesis inhibitor
0,680  0,015  TNF expression inhibitor
0,670  0,005  Antineoplastic (brain cancer)
0,665  0,004  Septic shock treatment
0,666  0,007  Antidiabetic (type 2)
0,664  0,006  DNA damaging
0,657  0,003  Interleukin 2 agonist
0,657  0,003  Carcinogenic, group 1
0,665  0,012  Antibacterial
0,655  0,005  Vascular (periferal) disease treatment
0,658  0,017  Antileukemic
0,648  0,009  Proliferative diseases treatment
0,646  0,008  Antiparasitic
0,633  0,002  Triose-phosphate isomerase inhibitor
0,633  0,002  Antihemorrhagic
0,647  0,026  Transcription factor NF kappa B inhibitor
0,624  0,004  Melanin inhibitor
0,628  0,009  Caspase 3 stimulant
0,618  0,003  Antifungal enhancer
0,621  0,006  Antihelmintic
0,618  0,003  VCAM1 expression inhibitor
0,617  0,004  ICAM1 expression inhibitor
0,614  0,002  Selectin antagonist
0,616  0,015  Immunostimulant
0,611  0,012  Immunosuppressant
0,606  0,010  Antipruritic, allergic
0,592  0,004  UGT2B4 substrate
0,597  0,015  Sensitization
0,587  0,007  Antineoplastic (osteosarcoma)
0,584  0,004  NOS3 expression enhancer
0,583  0,005  Myocardial infarction treatment
0,582  0,006  Antineoplastic (lymphoma)
0,582  0,007  UGT1A1 substrate
0,584  0,009  Antifungal
0,601  0,029  CYP3A4 substrate
0,575  0,005  Skin whitener
0,570  0,005  Anesthetic general
0,564  0,001  UDP-glucose 4-epimerase inhibitor
0,575  0,014  Cytotoxic
0,564  0,006  Antihypertriglyceridemic
0,560  0,005  Antiviral (Herpes)
0,555  0,006  Genotoxic
0,550  0,004  Alkylator
0,543  0,002  Phosphofructokinase-1 inhibitor
0,570  0,029  Antineoplastic (solid tumors)
0,550  0,014  Antiischemic
0,548  0,015  AR expression inhibitor
0,537  0,005  Platelet adhesion inhibitor
0,546  0,020  Stroke treatment
0,534  0,009  Vasodilator
0,537  0,018  Antineoplastic (pancreatic cancer)
0,546  0,029  Antineoplastic (colorectal cancer)
0,553  0,037  Antineoplastic (lung cancer)
0,527  0,022  Carcinogenic
0,514  0,010  RNA-directed DNA polymerase inhibitor
0,508  0,006  Interferon gamma antagonist
0,509  0,008  Antineoplastic (sarcoma)
0,500  0,004  Acute respiratory distress syndrome (ARDS) treatment
0,497  0,004  Protein kinase stimulant
0,493  0,008  Radiosensitizer
0,503  0,022  Ulceration
0,508  0,032  Antineoplastic (colon cancer)
0,483  0,008  Monophenol monooxygenase inhibitor
0,479  0,004  Cell adhesion inhibitor
0,479  0,005  Antiviral (Influenza)
0,476  0,005  Antidiabetic (type 1)
0,473  0,004  Expectorant
0,469  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,492  0,028  Antineoplastic (ovarian cancer)
0,504  0,053  Antineoplastic (breast cancer)
0,458  0,008  Antihypotensive
0,449  0,005  Antipruritic, non-allergic
0,447  0,005  Topoisomerase I inhibitor
0,455  0,015  Antineoplastic (liver cancer)
0,440  0,003  Antispirochetal
0,451  0,020  Antipyretic
0,435  0,006  Hemostatic
0,467  0,038  Prostate cancer treatment
0,429  0,004  Hexokinase inhibitor
0,436  0,014  Wound healing agent
0,425  0,005  Antineoplastic antibiotic
0,425  0,006  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,422  0,004  Antihelmintic (Nematodes)
0,457  0,046  CYP2C9 substrate
0,421  0,011  Non-steroidal antiinflammatory agent
0,423  0,014  Cyclic AMP phosphodiesterase inhibitor
0,411  0,002  Toll-Like receptor 4 antagonist
0,410  0,006  Peptidyltransferase inhibitor
0,452  0,049  Histamine release inhibitor
0,407  0,005  Mediator release inhibitor
0,403  0,007  Sepsis treatment
0,428  0,033  Lipoprotein disorders treatment
0,397  0,004  Neuropathy treatment
0,396  0,004  AMP-activated protein kinase stimulant
0,394  0,003  Mannose-6-phosphate isomerase inhibitor
0,395  0,005  Dementia treatment
0,395  0,006  DNA polymerase I inhibitor
0,424  0,036  Antineoplastic (melanoma)
0,392  0,005  Vascular dementia treatment
0,404  0,019  Sedative
0,388  0,006  Neurotrophic factor enhancer
0,405  0,024  Antidiabetic symptomatic
0,382  0,002  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,382  0,003  Photosensitizer
0,434  0,059  5 Hydroxytryptamine release inhibitor
0,380  0,007  Glutathione S-transferase substrate
0,383  0,010  Lipid peroxidase inhibitor
0,382  0,012  Restenosis treatment
0,378  0,009  Antineoplastic (gastric cancer)
0,398  0,030  Antiprotozoal (Leishmania)
0,395  0,029  Huntington's disease treatment
0,373  0,007  Carcinogenic, group 2B
0,369  0,004  DNA repair enzyme inhibitor
0,378  0,013  DNA methylase inhibitor
0,366  0,003  Phosphorylase inhibitor
0,373  0,013  Antineoplastic (squamous cell carcinoma)
0,379  0,024  Antineoplastic (endocrine cancer)
0,393  0,037  Antineoplastic (cervical cancer)
0,358  0,007  Antitussive
0,354  0,005  Nitric-oxide synthase stimulant
0,377  0,029  Antineoplastic (renal cancer)
0,377  0,032  Platelet antagonist
0,346  0,003  Glutamate release inhibitor
0,422  0,082  Antiarthritic
0,383  0,044  Spasmolytic
0,342  0,003  Carbonic anhydrase XIV inhibitor
0,336  0,001  Sodium/glucose cotransporter inhibitor
0,339  0,004  Antiviral (Influenza B)
0,354  0,022  GST M1-1 substrate
0,339  0,008  Psychosexual dysfunction treatment
0,341  0,011  Antidote
0,376  0,047  Antimycobacterial
0,339  0,011  Diabetic nephropathy treatment
0,414  0,087  Alzheimer's disease treatment
0,335  0,009  Insulin secretagoues
0,384  0,058  Angiogenesis inhibitor
0,357  0,033  Amyloid beta aggregation inhibitor
0,323  0,001  Glucose-6-phosphate isomerase inhibitor
0,329  0,009  Cell wall synthesis inhibitor
0,362  0,043  Antineoplastic (glioma)
0,320  0,003  Interferon agonist
0,331  0,015  Topoisomerase II inhibitor
0,327  0,011  Antidiarrheal
0,319  0,004  Transcription factor NF kappa B stimulant
0,386  0,073  GST A substrate
0,332  0,019  Thrombolytic
0,326  0,014  Antiviral (Influenza A)
0,344  0,037  Antineoplastic (small cell lung cancer)
0,354  0,049  Metabolic disease treatment
0,355  0,049  CYP2C19 substrate
0,310  0,005  Choleretic
0,305  0,005  ATPase inhibitor
0,316  0,016  Muscular dystrophy treatment
0,344  0,044  Antineoplastic (non-small cell lung cancer)
0,305  0,009  Antiprotozoal (Coccidial)
0,329  0,034  Antiulcerative
0,298  0,004  CF transmembrane conductance regulator agonist
0,301  0,012  Aldehyde dehydrogenase inhibitor
0,306  0,016  Liver fibrosis treatment
0,293  0,004  Mucolytic
0,294  0,006  Cyclooxygenase 3 inhibitor
0,334  0,048  Antineoplastic (multiple myeloma)
0,288  0,005  Antiviral (Ebola)
0,296  0,014  Antiviral (Hepatitis B)
0,297  0,015  Antineoplastic antimetabolite
0,310  0,028  Myocardial ischemia treatment
0,319  0,039  UGT1A6 substrate
0,307  0,031  Antiviral (HIV)
0,317  0,044  Hypolipemic
0,298  0,027  DNA methyltransferase I inhibitor
0,298  0,029  Anticoagulant
0,276  0,007  Antifungal (Cryptococcus)
0,290  0,022  Acaricide
0,277  0,010  Interleukin 4 antagonist
0,295  0,029  Eye irritation, high
0,313  0,048  Antiamyloidogenic
0,266  0,002  Heparanase inhibitor
0,307  0,045  Antineoplastic (glioblastoma multiforme)
0,276  0,018  Interleukin 6 antagonist
0,261  0,003  Phosphodiesterase 6D inhibitor
0,267  0,010  Xanthine oxidase inhibitor
0,281  0,024  Antiviral (Hepatitis)
0,262  0,008  Beta glucuronidase inhibitor
0,257  0,003  Antiviral (Dengue virus)
0,253  0,001  Sodium/glucose cotransporter 2 inhibitor
0,260  0,008  Carbonic anhydrase XIII inhibitor
0,294  0,045  Antineoplastic (lymphocytic leukemia)
0,260  0,013  Sulfotransferase substrate
0,254  0,006  Antirickettsial
0,249  0,003  Interferon inducer
0,250  0,005  Chronic obstructive bronchitis treatment
0,256  0,011  Antiviral (Poxvirus)
0,253  0,009  Antibiotic
0,254  0,010  Retinoprotector
0,261  0,018  Adenylate cyclase inhibitor
0,248  0,004  Sphingomyelinase inhibitor
0,246  0,005  Vanilloid 1 agonist
0,253  0,012  UGT2B10 substrate
0,249  0,010  Adenylate kinase inhibitor
0,266  0,027  Antineoplastic (carcinoma)
0,275  0,036  Osteoarthritis treatment
0,335  0,100  Antiprotozoal
0,331  0,097  Antiobesity
0,243  0,010  Topoisomerase II alpha inhibitor
0,241  0,011  Microtubule formation inhibitor
0,246  0,017  DNA intercalator
0,237  0,011  Antischistosomal
0,263  0,037  UGT2B7 substrate
0,228  0,005  Adenylate cyclase stimulant
0,223  0,004  Protein 50S ribosomal subunit inhibitor
0,238  0,019  Uterine stimulant
0,272  0,056  Gastrin inhibitor
0,219  0,003  Gaucher disease treatment
0,216  0,003  Antibiotic Glycopeptide-like
0,240  0,027  Phospholipase C inhibitor
0,222  0,017  Antibacterial (Helicobacter pylori)
0,203  0,001  Sodium/glucose cotransporter 1 inhibitor
0,205  0,003  Glucosylceramidase inhibitor
0,210  0,013  Growth stimulant
0,228  0,031  Cystic fibrosis treatment
0,230  0,034  Antiacne
0,208  0,015  Carbonic anhydrase III inhibitor
0,304  0,113  Antineoplastic (myeloid leukemia)
0,194  0,004  Glycine receptor antagonist
0,204  0,015  Beta amyloid protein antagonist
0,195  0,009  Thioredoxin inhibitor
0,190  0,004  Ca2+-transporting ATPase inhibitor
0,220  0,035  UGT2B15 substrate
0,198  0,015  Hearing loss treatment
0,198  0,016  Antihelmintic (Trematoda)
0,189  0,008  Carbamoyl phosphate synthetase inhibitor
0,212  0,035  Antiviral (Hepatitis C)
0,181  0,005  Histone deacetylase SIRT1 stimulant
0,181  0,005  Histone deacetylase stimulant
0,230  0,055  Abortion inducer
0,189  0,018  Constipation treatment
0,261  0,091  Hypoxia-inducible factor 1 alpha inhibitor
0,172  0,003  Na+ K+ transporting ATPase inhibitor
0,170  0,003  Antimycoplasmal
0,171  0,005  GABA aminotransferase inhibitor
0,264  0,099  CYP2D6 substrate
0,169  0,005  Phosphodiesterase VI inhibitor
0,206  0,042  Hair growth stimulant
0,191  0,028  Toll-Like receptor 2 antagonist
0,278  0,115  Calcium channel activator
0,161  0,002  Cholesterol absorption inhibitor
0,174  0,015  Heat shock protein 70 antagonist
0,174  0,016  Carbonic anhydrase VI inhibitor
0,190  0,034  Toll-Like receptor antagonist
0,215  0,059  Insulin sensitizer
0,185  0,031  Cholesterol synthesis inhibitor
0,163  0,010  UGT2B11 substrate
0,182  0,029  Cystathionine beta-synthase inhibitor
0,173  0,021  Antiviral (CMV)
0,164  0,012  Antifungal (Pneumocystis)
0,150  0,001  Antibiotic Aminoglycoside-like
0,216  0,071  Antialcoholic
0,158  0,014  Cell adhesion molecule inhibitor
0,153  0,011  Toll-Like receptor 2 agonist
0,186  0,047  Arachidonic acid antagonist
0,150  0,012  Antimetabolite
0,218  0,080  Antiviral (West Nile virus)
0,179  0,043  Carcinogenic, group 3
0,178  0,043  Alkaline phosphatase inhibitor
0,153  0,020  Neutropenia treatment
0,142  0,009  ATPase (Vacuolar H+) inhibitor
0,292  0,164  Calcium channel L-type activator
0,136  0,009  Glycine receptor agonist
0,134  0,008  Antiviral (Herpesvirus 3, Human)
0,182  0,056  Cytidine deaminase inhibitor
0,131  0,005  Phosphoglycerate kinase inhibitor
0,126  0,003  Cytokine production stimulant
0,144  0,023  Antiprotozoal (Toxoplasma)
0,126  0,005  Factor IXa inhibitor
0,249  0,128  FMO1 substrate
0,138  0,017  Interleukin 12 antagonist
0,149  0,029  Aldehyde dehydrogenase substrate
0,149  0,029  UGT2B1 substrate
0,174  0,055  UGT2B9 substrate
0,118  0,002  Protein 30S ribosomal subunit inhibitor
0,131  0,018  Antileprosy
0,202  0,090  Cardiodepressant
0,118  0,007  Antitreponemal
0,136  0,025  GST T1-1 substrate
0,263  0,153  Atherosclerosis treatment
0,146  0,036  Alcohol dehydrogenase substrate
0,130  0,020  Glutamate dehydrogenase inhibitor
0,185  0,076  P-glycoprotein inhibitor
0,112  0,004  Adenine nucleotide translocase inhibitor
0,197  0,089  Antineoplastic enhancer
0,120  0,013  Narcotic antagonist
0,129  0,022  Antiviral (Trachoma)
0,120  0,014  Biliverdin reductase inhibitor
0,133  0,027  Alcohol dehydrogenase inhibitor
0,116  0,012  Antidote, heavy metal
0,116  0,013  Acyl-CoA dehydrogenase inhibitor
0,108  0,005  Inosine monophosphate dehydrogenase inhibitor
0,105  0,002  Uridine phosphorylase inhibitor
0,176  0,077  Diabetic retinopathy treatment
0,114  0,016  Argininosuccinate synthase inhibitor
0,110  0,014  Neuraminidase (influenza) inhibitor
0,097  0,006  Adenosine deaminase inhibitor
0,108  0,018  Carbonic anhydrase XII inhibitor
0,140  0,050  Protein-tyrosine phosphatase 1B inhibitor
0,138  0,049  Interleukin 1b antagonist
0,132  0,043  Protein kinase C gamma inhibitor
0,103  0,015  Purinergic P2X1 antagonist
0,093  0,005  Equilibrative nucleoside transport protein inhibitor
0,091  0,004  Nucleoside transporters inhibitor
0,123  0,036  Uric acid excretion stimulant
0,148  0,061  Neurotrophic factor
0,128  0,041  Anticataract
0,093  0,007  Thymidine kinase inhibitor
0,119  0,033  Actinic keratosis treatment
0,089  0,003  Ceramide glucosyltransferase inhibitor
0,117  0,031  Aminoacyl-tRNA synthetase inhibitor
0,156  0,072  Protein-tyrosine phosphatase inhibitor
0,140  0,057  Antihyperlipoproteinemic
0,127  0,045  HDL-cholesterol increasing
0,102  0,019  Prokinetic
0,093  0,012  Nitric oxide donor
0,112  0,031  Restless leg syndrome treatment
0,088  0,008  Anesthetic inhalation
0,251  0,172  CYP2C19 inhibitor
0,081  0,003  Guanylate cyclase inhibitor
0,165  0,087  Succinate dehydrogenase inhibitor
0,111  0,034  Antidote, mercury
0,217  0,139  Bone diseases treatment
0,094  0,019  Protein kinase C eta inhibitor
0,101  0,026  Adenosine A3 receptor antagonist
0,084  0,010  Glucose-6-phosphate translocase inhibitor
0,204  0,129  Transcription factor STAT3 inhibitor
0,076  0,002  GRP78 expression inhibitor
0,093  0,019  Aldose reductase inhibitor
0,082  0,009  Squalene epoxidase inhibitor
0,098  0,026  T cell inhibitor
0,079  0,007  Fumarate hydratase inhibitor
0,203  0,133  Transcription factor STAT inhibitor
0,091  0,022  Carbonic anhydrase IX inhibitor
0,115  0,047  GST P1-1 substrate
0,207  0,138  5 Hydroxytryptamine uptake stimulant
0,075  0,007  Arginase inhibitor
0,086  0,018  Antiviral (Parainfluenza)
0,088  0,021  Protein kinase C beta inhibitor
0,118  0,051  Acetylcholine release stimulant
0,124  0,057  Skin irritative effect
0,216  0,149  CTGF expression inhibitor
0,179  0,112  Antiglaucomic
0,113  0,047  Anabolic
0,106  0,041  Antiviral (Rhinovirus)
0,067  0,002  Vanilloid 2 agonist
0,086  0,022  Neuraminidase inhibitor
0,081  0,017  Andropause treatment
0,065  0,001  Antibiotic Anthracycline-like
0,062  0,001  Telomerase stimulant
0,108  0,047  Tourette's syndrome treatment
0,067  0,006  Hypoxanthine phosphoribosyltransferase inhibitor
0,106  0,047  Lanosterol 14 alpha demethylase inhibitor
0,096  0,038  Vanilloid agonist
0,108  0,051  Antifibrinolytic
0,081  0,024  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,058  0,003  Toll-Like receptor 4 agonist
0,124  0,070  Gastritis treatment
0,129  0,075  CC chemokine 6 receptor antagonist
0,222  0,169  Antiprotozoal (Plasmodium)
0,202  0,151  CYP1A2 substrate
0,101  0,051  Antifungal (Candida)
0,054  0,003  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,134  0,084  SULT1A3 substrate
0,070  0,021  Lipocortins synthesis agonist
0,072  0,025  Ornithine carbamoyltransferase inhibitor
0,085  0,038  Lipase inhibitor
0,123  0,078  Antineoplastic (uterine cancer)
0,048  0,004  Ileal bile acid transport inhibitor
0,061  0,017  Factor III inhibitor
0,078  0,034  Anticholelithogenic
0,049  0,006  Adenosine A1 receptor agonist
0,111  0,068  Myasthenia Gravis treatment
0,059  0,016  Microtubule stabilization
0,047  0,005  Inosine monophosphate dehydrogenase 1 inhibitor
0,108  0,066  Excitatory amino acid transporter EAAC1 inhibitor
0,078  0,036  Carbonic anhydrase inhibitor
0,071  0,033  Hypercalcemia treatment
0,115  0,078  Contraceptive female
0,086  0,048  Thioredoxin reductase inhibitor
0,067  0,030  Alcohol oxidase inhibitor
0,139  0,104  Prostate disorders treatment
0,090  0,055  Interleukin 5 antagonist
0,092  0,059  Paget's disease treatment
0,052  0,021  Neuraminidase (Influenza A) inhibitor
0,037  0,007  Thymidine phosphorylase inhibitor
0,148  0,118  Psychostimulant
0,178  0,148  Antituberculosic
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,062  0,034  Carbonic anhydrase II inhibitor
0,030  0,005  Isoleucine-tRNA ligase inhibitor
0,038  0,012  Protein kinase C beta I inhibitor
0,139  0,114  Tumour necrosis factor antagonist
0,040  0,016  Melatonin 2 agonist
0,052  0,030  Topoisomerase II beta inhibitor
0,027  0,005  Antibiotic Macrolide-like
0,217  0,196  Antineoplastic (non-Hodgkin's lymphoma)
0,038  0,016  Adenosine uptake inhibitor
0,065  0,044  CDC25B inhibitor
0,071  0,050  Histidine decarboxylase inhibitor
0,030  0,010  Adenosine kinase inhibitor
0,033  0,013  Purinergic P2Y15 antagonist
0,171  0,151  Antiosteoporotic
0,153  0,135  Growth factor agonist
0,094  0,076  Gout treatment
0,022  0,005  O6-alkylguanine-DNA alkyltransferase inhibitor
0,055  0,039  Carbonic anhydrase I inhibitor
0,018  0,002  Purinergic P2Y2 agonist
0,054  0,039  Postmenopausal disorders treatment
0,021  0,006  Purinergic P2 agonist
0,021  0,006  Purinergic receptor agonist
0,048  0,034  Cholesterol esterase inhibitor
0,067  0,053  SULT2A1 substrate
0,107  0,094  Antiprotozoal (Amoeba)
0,026  0,012  Motilin receptor agonist
0,020  0,008  Adenosine A2a receptor agonist
0,020  0,008  Adenosine A2 receptor agonist
0,019  0,007  Purinergic P2Y1 agonist
0,110  0,099  Antiviral (Papilloma)
0,023  0,013  Corticosteroid-like
0,019  0,009  Adenosine A3 receptor agonist
0,019  0,010  Methylmalonyl-CoA mutase inhibitor
0,016  0,006  Purinergic P2Y agonist
0,112  0,103  Antiprotozoal (Trichomonas)
0,056  0,047  Sphingosine kinase inhibitor
0,054  0,045  Postcoital contraceptive
0,027  0,019  Purinergic P2X agonist
0,067  0,059  Arylamine N-Acetyltransferase substrate
0,020  0,012  Apical sodium codependent bile acid transporter inhibitor
0,055  0,048  Androgen agonist
0,053  0,046  Adenosine A1 receptor antagonist
0,024  0,016  Somatostatin 4 antagonist
0,016  0,009  Adenosine A2b receptor agonist
0,016  0,009  S-adenosyl-L-homocysteine hydrolase inhibitor
0,123  0,117  Antinephritic
0,032  0,026  Sodium-dependent vitamin C transporter 2 inhibitor
0,041  0,036  AICAR transformylase inhibitor
0,080  0,076  Granulocyte macrophage colony stimulating factor agonist
0,005  0,001  Purinergic P2Y6 agonist
0,052  0,049  Prostaglandin EP2 antagonist
0,050  0,047  Peristaltic stimulant
0,032  0,029  HMG CoA reductase inhibitor
0,038  0,036  Hypogonadism treatment
0,020  0,018  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,031  0,031  Tubulin agonist
0,117  0,116  Skeletal muscle relaxant

